Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citrus/Cydonia comp. 1% injections for grass pollen seasonal allergic rhinitis
NL-OMON34862Phase 3Not yet recruiting
- Sponsor
- Weleda
- Start
- Feb 2013
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in seasonal allergic rhinitis (SAR) and allergic rhinitis (AR) comparing Gencydo subcutaneous injection with Placebo saline injection (2 arms). Primary endpoint: Days with symptom control. Planned start Feb 2013; status: not yet recruiting.
02
Drugs
Citrus + Cydonia comp.
03
Conditions
seasonal allergic rhinitis (SAR)allergic rhinitis (AR)
Beyond the preview
Go deeper on NL-OMON34862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34862.